Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1970.00 | 1955.00 | 1.0077 | 1.0124 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1211.00 | 1955.00 | 0.6194 | 0.3571 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 1678.00 | 1955.00 | 0.8583 | 0.7673 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 2049.00 | 1955.00 | 1.0481 | 1.0775 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2218.00 | 1955.00 | 1.1345 | 1.2152 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 1250.00 | 830.55 | 1976.00 | 1955.00 | 1.0107 | 1.0174 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2409.00 | 1955.00 | 1.2322 | 1.3684 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 940.00 | 1955.00 | 0.4808 | 0.1054 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 830.55 | 2252.00 | 1955.00 | 1.1519 | 1.2427 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2304.00 | 1955.00 | 1.1785 | 1.2845 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 830.55 | 1777.00 | 1955.00 | 0.9090 | 0.8512 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 987.00 | 1955.00 | 0.5049 | 0.1500 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 1905.00 | 1955.00 | 0.9744 | 0.9585 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 1250.00 | 830.55 | 623.00 | 1955.00 | 0.3187 | -0.2077 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2087.00 | 1955.00 | 1.0675 | 1.1087 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1993.00 | 1955.00 | 1.0194 | 1.0314 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 1841.00 | 1955.00 | 0.9417 | 0.9050 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1901.00 | 1955.00 | 0.9724 | 0.9552 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1449.00 | 1955.00 | 0.7412 | 0.5693 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1801.00 | 1955.00 | 0.9212 | 0.8715 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1537.00 | 1955.00 | 0.7862 | 0.6460 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 856.00 | 1955.00 | 0.4379 | 0.0247 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1354.00 | 1955.00 | 0.6926 | 0.4855 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2298.00 | 1955.00 | 1.1754 | 1.2797 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2197.00 | 1955.00 | 1.1238 | 1.1982 |